Egon Kárpáti Selected Research

apovincaminic acid

1/2002

[Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Egon Kárpáti Research Topics

Disease

5	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2003 - 01/2002
3	Stroke (Strokes) 11/2002 - 01/2002
2	Ischemic Stroke 11/2002 - 01/2002
1	Ataxia (Dyssynergia) 09/2005
1	Tremor (Tremors) 09/2005
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2002
1	Dementia (Dementias) 01/2002
1	Infarction (Infarctions) 01/2002

Drug/Important Bio-Agent (IBA)

5	vinpocetineIBA 11/2003 - 01/2002
4	Neuroprotective AgentsIBA 11/2003 - 01/2002
1	HarmalineIBA 09/2005
1	GYKI 20039IBA 09/2005
1	Morphine (MS Contin)FDA LinkGeneric 09/2005
1	Thiopental (Pentothal)FDA Link 09/2005
1	Oxygen (Dioxygen)IBA 11/2002
1	Glucose (Dextrose)FDA LinkGeneric 11/2002
1	P-30 composite resin (P 30)IBA 01/2002
1	Nimodipine (Modus)FDA LinkGeneric 01/2002
1	apovincaminic acidIBA 01/2002
1	VincamineIBA 01/2002
1	Dizocilpine Maleate (Dizocilpine)IBA 01/2002
1	posatirelinIBA 01/2002
1	triphenyltetrazoliumIBA 01/2002

Therapy/Procedure

1	Oral Administration 08/2002
1	Therapeutics 01/2002